FirmuSAN Capsules

Manufacturer
sanPharmacy Inc. | MEDsan Inc.
Effective date
2024-04-29
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 02:26:49

Label at a glance#

ProductFirmuSAN
Active ingredientBACILLUS FIRMUS
Label structure8 sections

Storage and handling

protect from light and heat

Label contents#

Full prescribing information#

Indications

INDICATIONS & USAGE SECTION

For joint and serous membrane inflammation

Purpose

OTC - PURPOSE SECTION

Relieves symptoms of joint and serous membrane inflammation

Dosage

DOSAGE & ADMINISTRATION SECTION

1-2 capsules per week, taken at least 1 hour before eating

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

Bacillus firmus 6X

Inactive ingeredients

INACTIVE INGREDIENT SECTION

mannitol

Warnings

WARNINGS SECTION

If pregnant or breast-feeding, ask a health professional before use.
______________________________
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away at 1-800-222-1222.
______________________________
When using this product
▪ do not use more than directed
______________________________
If symptoms persist more than 5 days, contact a licensed practitioner.
______________________________
Tamper Evident: Do not use product if tamper evident strip is broken. To report adverse events, contact MEDsan Inc. at 1-855-462-6334.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away at 1-800-222-1222

SPL UNCLASSIFIED SECTION

Manufactured in the USA for:
sanPharmacy Inc.
350 Fifth Avenue STE 5220
New York NY 10118-5220

Liability statement

SPL UNCLASSIFIED SECTION

These statements or claims are based upon traditional homeopathic practice. They have not been reviewed by the Food & Drug Administration

STORAGE AND HANDLING SECTION

protect from light and heat

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Inner-PackageInner-PackageOuter-PackageOuter-PackageFirmuSAN

Homeopathic Medicine

For joint and serous membrane inflammation

10 Capsules

sanPharmacy

biological health solutions

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a62a50ac-1535-4461-9768-8ae703e2e9fbProduct name120210525
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877Product name120140508
bc07ef78-e82d-0c19-31f4-31f263780582Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
73479-015-012025-07-29C16284748780-13b156c62-25bf-fb37-e063-e6dba90a4e07FirmuSAN Capsules

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
73479-015-01FirmuSAN1 in 1 CARTONCAPSULE11
73479-015-01FirmuSAN10 in 1 CANCAPSULE101

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
73479-015FIRMUSAN (BACILLUS FIRMUS) CAPSULE [SANPHARMACY INC.]12 package rows20240501_173a15e7-478f-45c4-e063-6394a90aca7e.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
73479-01573479-015-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
MANNITOL3OWL53L36AIACT
BACILLUS FIRMUSD6U864H4DTACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
173a15e7-4790-45c4-e063-6394a90aca7e173a15e7-478f-45c4-e063-6394a90aca7e2024-04-29WarningsExact identifier
spl id: 173a15e7-4790-45c4-e063-6394a90aca7e
spl set id: 173a15e7-478f-45c4-e063-6394a90aca7e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.